Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Emyria
Emyria
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Emyria
Stock Price
$0
2024-10-04
Market Capitalization
$13.7 M
2024-10-04
Revenue
$1.3 M
FY, 2025
Emyria Summary
Company Summary
Overview
Emyria is a company that provides healthcare services. It offers clinical research, data science, mental health, cannabinoid medicine, and other services.
Type
Public
Status
Active
Founded
2018
Website
https://www.emeraldclinics.com.au
Cybersecurity rating
Sectors
Healthcare
clinical research
mental health
Homepage
Linkedin
instagram
facebook
twitter
Table of Contents
Financials
Competitors
Emyria Financials
Summary Financials
Revenue (H1, 2026)
$1.6M
Gross profit (H1, 2026)
$409.0K
Net income (H1, 2026)
($2.4M)
Cash (H1, 2026)
$10.5M
EBIT (H1, 2026)
($2.3M)
Competitors and Similar Companies
Ultra Medica
Healthcare - Private
EvolvedMD
Healthcare - Private
Clerkenwell Health
Healthcare - Private
CBH Health
Healthcare - Subsidiary
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top